WallStSmart
TBPH

Theravance Biopharma Inc

NASDAQ: TBPH · HEALTHCARE · BIOTECHNOLOGY

$16.52
-2.88% today

Updated 2026-05-11

Market cap
$876.78M
P/E ratio
7.63
P/S ratio
7.99x
EPS (TTM)
$2.23
Dividend yield
52W range
$8 – $21
Volume
0.6M

Theravance Biopharma Inc (TBPH) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20112012201320142015201620172018201920202021202220232024
Total assets$13.82M$20.96M$25.18M$337.77M$300.12M$639.25M$441.40M$560.24M$408.83M$469.06M$374.82M$607.40M$382.00M$354.16M
Cash & equivalents$89.00M$89.22M$112.71M$344.71M$88.98M$378.02M$58.06M$81.47M$89.96M$298.17M$39.55M$37.80M
Current assets$2.32M$10.84M$14.11M$326.77M$237.47M$528.50M$378.75M$532.82M$338.49M$393.34M$249.87M$353.46M$133.54M$161.07M
Total liabilities$154.54M$22.67M$42.21M$47.98M$57.05M$289.02M$326.22M$611.82M$632.67M$772.81M$713.39M$165.60M$169.00M$178.62M
Current liabilities$35.88M$22.67M$36.85M$41.26M$49.47M$49.27M$62.55M$98.55M$111.70M$123.57M$58.59M$28.71M$24.77M$32.09M
Long-term debt$223.00M$0.00$0.00$222.68M$223.75M$454.35M$445.19M$226.96M$599.39M
Shareholder equity$-140.72M$-6.99M$-17.04M$289.79M$243.06M$350.23M$115.18M$-51.59M$-223.84M$-303.75M$-338.57M$441.80M$213.00M$175.54M
Retained earnings$-140.72M$-6.99M$-17.04M$-139.34M$-321.56M$-512.23M$-797.74M$-1.01B$-1.25B$-1.53B$-1.73B$-853.91M$-909.10M$-965.52M
Accounts receivable$424000.00$1.04M$1.13M$2.13M$37.15M$9.08M$7.11M$10.67M$50.57M$69.67M$57.60M$16.79M$17.47M$68.44M
Inventory$7.51M$10.41M$12.55M$10.01M$12.22M$16.83M$1.00$1.00$20.37M$10.24M$1.51M$1.00$-68.51M
Goodwill$0.00$0.00$0.00$0.00